EUVIMEDEUVIMED entdecken
Crossref

Analgesic efficacy of intravenous lidocaine vs ketamine in refractory chronic pain: a retrospective analytic study with 3-month follow-up

Kanita Kositanurit, Pornpan Chalermkitpanit, Noramon Limtrakool, Sireedhorn Assavanop iD

Pain Medicine · 2026

DOI: 10.1093/pm/pnag022 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pain Medicine, 2026. Verfasst von Kanita Kositanurit und 3 weiteren Autor:innen. Beteiligte Einrichtung: Pain Management Research Unit, Department of Anesthesiology, Faculty of Medicine, Chulalongkorn University, King Chulalongkorn Memorial Hospital, Ban…. Hauptthemen laut MEDLINE: Ketamine, Lidocaine, Analgesics, Chronic Pain. Die Arbeit nennt 25 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Refractory chronic pain conditions remain challenging to manage, and intravenous infusions of ketamine, lidocaine, or their combination have emerged as potential therapeutic options.

Objective

To evaluate the analgesic effectiveness and safety of intravenous lidocaine, ketamine, and their combination in patients with refractory chronic pain.

Methods

We conducted a retrospective analytic study of patients treated between January 2020 and November 2024 at an outpatient pain clinic. Eligible patients had persistent severe pain (numerical rating scale [NRS] > 6/10) despite ≥3 months of multimodal pain management and received intravenous lidocaine, ketamine, or combination infusions. The primary outcome was immediate pain reduction post-infusion. Secondary outcomes included pain relief at 1 and 3 months, quality of life (QoL) assessed by EQ-5D-5L, and associations between clinical characteristics and treatment response.

Results

A total of 120 patients were included. All 3 groups demonstrated significant reductions in NRS scores from baseline after the first infusion, with mean differences of 3.09 (95% CI 2.56-3.62) for lidocaine, 2.30 (95% CI 1.48-3.13) for ketamine, and 3.95 (95% CI 3.33-4.57) for combination therapy. Analgesic effects persisted at 1- and 3-month follow-up. Mild, self-limiting adverse effects occurred in 7.5% of patients. The combination group showed superior pain reduction at selected time points and greater improvements in QoL at 3 months.

Conclusions

Intravenous lidocaine, ketamine, and combination infusions provide immediate and sustained pain relief in refractory chronic pain. Combination therapy may offer additional benefit beyond monotherapy, supporting its consideration in clinical practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

KetamineLidocaineAnalgesicsChronic PainAnesthetics, LocalIntractable PainHumansRetrospective StudiesFemaleMaleFollow-Up StudiesMiddle AgedTreatment OutcomeInfusions, IntravenousQuality of LifePain MeasurementAgedAdult

Stichwörter der Autor:innen

ketamine infusionlidocaine infusionrefractory chronic pain

Substanzen

KetamineLidocaineAnalgesicsAnesthetics, Local

Autor:innen und Institutionen

  • Pain Management Research Unit, Department of Anesthesiology, Faculty of Medicine, Chulalongkorn University, King Chulalongkorn Memorial Hospital, Bangkok, Thailand.

ORCID-Profile: Sireedhorn Assavanop

Zitieren

APA

Kositanurit, K., Chalermkitpanit, P., Limtrakool, N., & Assavanop, S. (2026). Analgesic efficacy of intravenous lidocaine vs ketamine in refractory chronic pain: a retrospective analytic study with 3-month follow-up. Pain Medicine. https://doi.org/10.1093/pm/pnag022

Vancouver

Kositanurit K, Chalermkitpanit P, Limtrakool N, Assavanop S. Analgesic efficacy of intravenous lidocaine vs ketamine in refractory chronic pain: a retrospective analytic study with 3-month follow-up. Pain Medicine. 2026. doi:10.1093/pm/pnag022

BibTeX
@article{Kositanurit2026,
  author = {Kositanurit, Kanita and Chalermkitpanit, Pornpan and Limtrakool, Noramon and Assavanop, Sireedhorn},
  title = {Analgesic efficacy of intravenous lidocaine vs ketamine in refractory chronic pain: a retrospective analytic study with 3-month follow-up},
  journal = {Pain Medicine},
  year = {2026},
  doi = {10.1093/pm/pnag022}
}
Kostenlos starten →